West Pharmaceutical Services holds the cleaner structural position, with profitability as the main driver and growth adding further support. Eurofins Scientific SE does not offset that deficit through any equally strong structural edge elsewhere. In the market, Eurofins Scientific SE carries the stronger setup — intact trend against West Pharmaceutical Services's broken trend. That leaves a split case: the structural lead stays with West Pharmaceutical Services, but the market is not currently confirming it.
The comparison is based on similar long-term financial trajectories, not sector labels.
Profitability remains the main source of distance in the comparison. The overall score gap is 26 points in favour of West Pharmaceutical Services, Inc..
These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.
This level of similarity signals a strong structural match, even though some dimensions still separate the two companies.
Most of the shared profile comes through revenue growth trajectory and capital structure.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
Score differences across key dimensions.
Left means cheaper relative valuation. Higher means stronger structure.
The setup stays mixed because structure and the price setup do not align cleanly in one direction.
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
The profitability lead is mainly driven by a 8.4-point operating margin advantage.
Eurofins Scientific SE still shows lower market-fundamental divergence, which keeps the wider picture mixed rather than completely one-sided.
Profitability is the clearest driver, and growth also supports West Pharmaceutical Services, Inc.'s broader structural position.
Break down the ERF.PA vs WST comparison across all dimensions with the full interactive tool.
Explore how ERF.PA and WST each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.